QQ客服 官方微博 反馈留言

	EGFR/HER2 inhibitors effectively reduce the malignant potential of MDR breast cancer evoked by P-gp substrates in vitro and in vivo
	Jin, Yiting; Zhang, Wei; Wang, Hongying; Zhang, Zijing; Chu, Chengyu; Liu, Xiuping; Zou, Qiang
刊名	ONCOLOGY REPORTS
	2016
卷号	35期号:2
关键词	EGFR/HER2 inhibitor breast cancer multidrug resistance metastasis
ISSN号	1021-335X
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3626081
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Jin, Yiting,Zhang, Wei,Wang, Hongying,et al. EGFR/HER2 inhibitors effectively reduce the malignant potential of MDR breast cancer evoked by P-gp substrates in vitro and in vivo[J]. ONCOLOGY REPORTS,2016,35(2).
APA	Jin, Yiting.,Zhang, Wei.,Wang, Hongying.,Zhang, Zijing.,Chu, Chengyu.,...&Zou, Qiang.(2016).EGFR/HER2 inhibitors effectively reduce the malignant potential of MDR breast cancer evoked by P-gp substrates in vitro and in vivo.ONCOLOGY REPORTS,35(2).
MLA	Jin, Yiting,et al."EGFR/HER2 inhibitors effectively reduce the malignant potential of MDR breast cancer evoked by P-gp substrates in vitro and in vivo".ONCOLOGY REPORTS 35.2(2016).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。